SOTIO will gain access to Synaffix’s three ADC technologies
SOTIO will gain access to Synaffix’s three ADC technologies
Automated analysis of language could help diagnose and assess psychiatric conditions
The projects will support the development of new and longer-lasting vaccines
The financing will support the biotech’s clinical study of people with AD as a lead programme
The service will benefit major research and industry projects across the UK
The deal gives Kyowa access to a therapy for early-onset metachromatic leukodystrophy
Eligible patients in Scotland will now have access to Nubeqa and Stivarga
The scheme will help ten projects establish research and innovation clusters
Researchers focused on four of the most common heart conditions in the UK
The study will offer new insights into the immune system’s response to iGAS
The agreement builds on the companies’s existing partnership
NPIP will transform medical research and provide better outcomes for patients
The study used data from 50,000 people in the UK Biobank
The research approach will help small- to mid-sized organisations to advance their clinical studies
It will be the company’s first platform to be installed in an external scientific setting